The 13-valent pneumococcal conjugate vaccine (PCV13) has obtained the corresponding drug production license and has submitted ...

With half of hospital admissions for pneumonia affecting young and middle-aged adults, experts emphasize ...

Vaxcyte is awaiting data from another vaccine candidate for invasive pneumococcal disease (IPD) before advancing to Phase III ...

Babies treated with antibiotics in the first few weeks of their life are likely to show weaker immune responses to essential vaccines taken in ...